Select a medication above to begin.
L-5-Hydroxytryptophan
5-HTP
Entire Monograph
Reported Uses
- NOTE: see Herb & Supplement Effectiveness Rating Definitions table
- ADHD [Insufficient Evidence]
- alcohol withdrawal sx [Insufficient Evidence]
- Alzheimer dementia [Insufficient Evidence]
- anxiety [Insufficient Evidence]
- cerebellar ataxia [Insufficient Evidence]
- depression [Possibly Effective]
- Down syndrome [Possibly Ineffective]
- fibromyalgia [Insufficient Evidence]
- menopausal sx [Insufficient Evidence]
- migraine prophylaxis [Insufficient Evidence]
- obesity [Insufficient Evidence]
- obsessive-compulsive disorder [Insufficient Evidence]
- opioid withdrawal sx [Insufficient Evidence]
- panic disorder [Insufficient Evidence]
- Parkinson dz [Insufficient Evidence]
- premenstrual syndrome [Insufficient Evidence]
- seizures [Insufficient Evidence]
- tension headache [Insufficient Evidence]
- tinnitus [Insufficient Evidence]
Reported Doses
Safety/efficacy may not be established; reported doses may be derived from limited or potentially inadequate studies w/ variable regimens, multi-ingredient products, or where concentration of active ingredients may vary widely
Effectiveness Ratings
- [see Herb & Supplement Effectiveness Rating Definitions table]
alcohol withdrawal sx
- [Insufficient Evidence]
- Dose: 5 mg PO qd
anxiety
- [Insufficient Evidence]
- Dose: 25-150 mg PO qd; Info: used w/ peripheral decarboxylase inhibitor
cerebellar ataxia
- [Insufficient Evidence]
- Dose: 10 mg/kg/dose PO qd
depression
- [Possibly Effective]
- Dose: 150-800 mg PO qd; Info: up to 3000 mg/day has been used
fibromyalgia
- [Insufficient Evidence]
- Dose: 100 mg PO tid
migraine prophylaxis
- [Insufficient Evidence]
- Dose: 600 mg PO qd
obesity
- [Insufficient Evidence]
- Dose: 250-300 mg PO tid; Info: give 30min before meals
obsessive-compulsive disorder
- [Insufficient Evidence]
- Dose: 200 mg PO qd; Info: used w/ selective serotonin reuptake inhibitor
opioid withdrawal sx
- [Insufficient Evidence]
- Dose: 200 mg PO qd
Parkinson dz
- [Insufficient Evidence]
- Dose: 50 mg PO qd; Info: used w/ peripheral decarboxylase inhibitor
Copyright © 2024. All Rights Reserved. Republication or redistribution, including by framing or similar means, is prohibited without the prior written consent of copyright holder.